Drugmakers stockpile medicines for Brexit

As uncertainty grows over the United Kingdom's exit from the EU, two of the world's biggest drugs companies are stockpiling medicines.

France's Sanofi is increasing its stocks by four weeks to give it a 14-week supply of medicines, while Switzerland's Novartis said it was also preparing for the possibility of a no-deal Brexit.

Supplies of thousands of medicines could be disrupted if Britain leaves the EU without a deal next March and border checks and lengthy transport delays arise.